Your browser doesn't support javascript.
loading
Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose Study.
Hug, Bruce A; Matheny, Christopher J; Burns, Olivia; Struemper, Herbert; Wang, Xiaowei; Washburn, Michael L.
Afiliação
  • Hug BA; R&D Pharmaceuticals, GSK, Upper Providence, PA, USA. Electronic address: bruce.a.hug@gsk.com.
  • Matheny CJ; R&D Pharmaceuticals, GSK, Upper Providence, PA, USA.
  • Burns O; Global Clinical Sciences & Delivery, GSK, Abbotsford, Victoria, Australia.
  • Struemper H; Clinical Pharmacology Modeling & Simulation, GSK, Research Triangle Park, NC, USA.
  • Wang X; R&D Pharmaceuticals, GSK, Upper Providence, PA, USA.
  • Washburn ML; R&D Pharmaceuticals, GSK, Upper Providence, PA, USA.
Clin Ther ; 42(8): 1519-1534.e33, 2020 08.
Article em En | MEDLINE | ID: mdl-32739049
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicolipídeos / Receptor 4 Toll-Like / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicolipídeos / Receptor 4 Toll-Like / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article